Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
The study examined whether acupuncture could improve Parkinsonism and correct gut microbial dysbiosis in mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a standard model of Parkinson's disease (PD). Researchers applied acupuncture at the acupoints GB34 and ST36 and assessed motor function, anxiety-like behavior, dopaminergic neuron and fiber levels, neuroinflammatory and apoptotic markers, and gut microbiota composition via 16S rRNA sequencing. The work rests on the premise that the gut-brain axis is a promising therapeutic target for PD.
Who was studied?
The subjects were mice given MPTP to induce a Parkinson's disease phenotype, then treated with acupuncture at GB34 and ST36 or left untreated for comparison. The abstract does not report an exact number of animals, strain, sex, or age, so no specific cohort size can be stated. This was a controlled animal model study rather than a human clinical trial.
What were the most important findings?
Acupuncture improved motor function and comorbid anxiety in the PD mice and increased dopaminergic fibers in the striatum and dopaminergic neurons in the substantia nigra. It also reduced the overexpression of microglia and astrocytes and normalized the Bax to Bcl-2 expression balance in both brain regions, indicating that acupuncture blocked inflammatory responses and apoptosis. Using 16S rRNA sequencing, the researchers found that acupuncture altered the relative abundance of 18 bacterial genera compared to untreated PD mice, including changes in Butyricimonas and Holdemania, showing that acupuncture also corrected gut microbial dysbiosis.
What are the greatest implications of this study?
The findings support acupuncture as a strategy that can act on both the brain and the gut microbiome in Parkinson's disease, reinforcing the gut-brain axis as a viable therapeutic target. By simultaneously reducing neuroinflammation, protecting dopaminergic neurons, and reshaping microbial community structure, acupuncture may offer a non-pharmacological complement to existing PD treatments. Further work in human populations would be needed to confirm whether these mouse-model effects translate to patients.